Navigation Links
Ambit Announces Participation At The BioCentury NewsMakers in the Biotech Industry Conference
Date:9/19/2013

SAN DIEGO, Sept. 19, 2013 /PRNewswire/ -- Ambit Biosciences (Nasdaq: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced the Company's participation at the BioCentury NewsMakers in the Biotech Industry conference at the Millennium Broadway Hotel in New York City on Friday, September 27, 2013.

Michael Martino, Ambit's CEO, will provide an overview of the Company and its lead drug candidate, quizartinib, at 8:30 a.m. EDT.  The presentation will be webcast live through the "Investors & Media" section of the Ambit website at www.ambitbio.com.  An audio replay will be available for 30 days following the initial presentation webcast. 

About Ambit Biosciences
Ambit is a biopharmaceutical company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. Ambit's lead drug candidate, quizartinib (AC220), is a once-daily, orally-administered potent and selective, inhibitor of FMS-like tyrosine kinase-3 (FLT3) and is currently under clinical development in patients with relapsed/refractory acute myeloid leukemia (AML) and in newly diagnosed AML patients in combination with chemotherapy as well as maintenance following a hematopoietic stem cell transplantation (HSCT). In addition to quizartinib, Ambit's clinical pipeline includes AC410, an oral JAK2 inhibitor, and CEP-32496, a BRAF inhibitor licensed to Teva Pharmaceutical Industries Ltd. Ambit's preclinical portfolio includes a proprietary CSF1R inhibitor program.Ambit Contacts:Marcy Graham

Ian Stone/
'/>"/>

SOURCE Ambit Biosciences
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Ambit Announces Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the Annual Meeting of the American Society of Clinical Oncology
2. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
3. APAC Stem Cell Research & Therapy Market a “Growth Engine” for Region’s Scientific Ambitions Says A New Market Research Report at ReportsnReports.com
4. Astellas and Ambit Announce Data Presentations Highlighting Quizartinib at the American Society of Hematology 54th Annual Meeting
5. Ambit Biosciences to Present at Two Upcoming Investor Conferences
6. Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society
7. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
8. Natural Skin Care Solution, Probiotic Action Announces the Use of Their Probiotic Cleanser As a Anti-Acne Body Wash
9. Creabilis Announces Treatment of First Patients in its Phase 2b Trial of CT327 in Pruritus in Atopic Dermatitis Patients
10. Neogen announces 1st quarter results conference call
11. Global Industry Analysts, Inc. Announces the Launch of a Major Research Program Analysing the Global Market for Circulating Tumor Cells and Cancer Stem Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 27, 2015 Empowering biomedical researchers ... disease, Cubresa Inc. today announced its MR Compatible ... in-bore PET Scanner uses silicon photomultiplier detector technology, ... MRI machines from manufacturers like Bruker and Agilent,” ... Winnipeg, Canada. “This enables simultaneous PET and MRI ...
(Date:5/27/2015)... , May 27, 2015  US-Australian drug discovery and ... announced today that it will present at the Brain Tumor ... on May 29, 2015. The venue is the ... Manhattan . The Brain Tumor Biotech ... the pharmaceutical industry and the investment community to promote innovative ...
(Date:5/26/2015)... 26, 2015 Regenestem Network ... cells clinic in Buenos Aires, Argentina. The clinic will ... care specialist. Pastrana has assembled a multidisciplinary team of ... in her state-of-the-art Puerto Madero office. , The ... to phase IV clinical studies in cellular therapies, and ...
(Date:5/26/2015)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ) announced today ... provide an update on the progress of Sangamo,s ZFP Therapeutic ... business strategy at 1:30pm ET on Monday, June 1, 2015, ... being held in New York, NY . ... be accessed via a link on the Sangamo BioSciences website ...
Breaking Biology Technology:Cubresa Launches Simultaneous PET/MRI Technology 2Novogen to Present at Brain Tumor Biotech Summit 2015 2Novogen to Present at Brain Tumor Biotech Summit 2015 3Novogen to Present at Brain Tumor Biotech Summit 2015 4Novogen to Present at Brain Tumor Biotech Summit 2015 5Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 2Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 3Sangamo BioSciences Announces Presentation At The Jefferies 2015 Global Healthcare Conference 2
... has been written, said, and even adjudicated about peer-to-peer music ... music service promising to legitimize song sharing. Yet Mercora ... 1.5 million people who have downloaded the software since its ... Mercora's IM Radio the IM stands for Individual Modulation ...
... Norlight Telecommunications Inc. plans to ... cable. , ,The company says it operates 3,800 miles ... more later this year. The Illinois expansion plans cover ... near Milwaukee and provides wholesale network access to clients ...
... — Sonic Foundry has made a new version of its ... it has sold 50 units to date and hopes to ... can synchronize a slide show such as a PowerPoint deck ... the presentation online as a webcast. , ,According to company ...
Cached Biology Technology:Mercora gets music sharing right 2Mercora gets music sharing right 3
(Date:5/22/2015)... CT , May 22, 2015  NXT-ID, Inc. (NASDAQ: ... June 1st, it will be ending its promotional pricing and ... . Laurence Savin , Head of Marketing ... exclusive promotional pricing until the end of May. To get ... wocketwallet.com/invite and when we open the store on June 1, ...
(Date:5/21/2015)... May 21, 2015 According ... Market by Solutions (Hardware, Software, Services), by Applications (Surveillance ... others), by End-Users (Military & Defense & Commercial) ... Thermal Imaging Market is expected to grow from ... 2020, at a Compound Annual Growth Rate (CAGR) ...
(Date:5/20/2015)... , May 20, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/h8t4x6/5year ) has announced the addition ... the Global Iris Recognition Market"  report ... , ,This research service analyses trends ... the government and commercial sectors, globally. ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2
... CRUZ, CA--The Genome 10K Community of Scientists and BGI (formerly ... plan to sequence the genomes of 101 vertebrate species within ... species to be sequenced by the Genome 10K Project. ... to gather specimens of thousands of animals from zoos, museums, ...
... Scientists are calling for radical new approaches to ... Led by the University of East Anglia (UEA), ... Suffolk Biodiversity Partnerships and County Councils, the Brecks Partnership, ... plant and animal species recorded in Breckland a ...
... are picky eaters: More than half of all species are ... -- between birth and adulthood. And a new study by ... Barbara, finds this pattern has major implications for the survival ... With thousands of species facing Earth,s sixth major mass extinction, ...
Cached Biology News:Genome 10K Project announces first 101 species for genome sequencing 2Genome 10K Project announces first 101 species for genome sequencing 3Pioneering study reveals UK biodiversity hotspot 2Pioneering study reveals UK biodiversity hotspot 3Pioneering study reveals UK biodiversity hotspot 4Study: Ecological effects of biodiversity loss underestimated 2